EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases

Nur Hendri Wahyu Firdaus, Buddhadev Mallick, Kutty Selva Nandakumar, Akhilesh Kumar Shakya iD

Journal of The Royal Society Interface · 2025-07 · 22 (228)

DOI: 10.1098/rsif.2025.0138 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of The Royal Society Interface, online erschienen am 02.07.2025. Verfasst von Nur Hendri Wahyu Firdaus und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Texas Tech University, Lubbock, TX, USA. Hauptthemen laut MEDLINE: Complement System Proteins, Vaccines, Immunity, Innate, Communicable Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The complement system, a vital component of innate immunity, is indispensable to our immune defence mechanisms against microbial infections. Acting as a surveillance mechanism, it identifies and eliminates pathogens by activating several complement components and associated signalling pathways, which are also implicated in various diseases and disorders. Beyond its defensive role, the complement system has emerged as a promising target for vaccine development in therapeutic and preventive regimens, offering new vaccine strategies to combat non-infectious and infectious diseases. Activation of the complement pathways by various natural and synthetic adjuvants enhances protective immune responses, highlighting its utility in vaccine design. This approach could be useful for targeting autoimmune diseases, infectious diseases, cancer and neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement System ProteinsVaccinesImmunity, InnateCommunicable DiseasesNeoplasmsComplement ActivationHumansAnimalsAutoimmune Diseases

Stichwörter der Autor:innen

adjuvantsautoimmunitycancercomplement systeminfectionsneurological disordersvaccine

Substanzen

Complement System ProteinsVaccines

Autor:innen und Institutionen

  • Department of Chemical Engineering, Texas Tech University, Lubbock, TX, USA.
  • Department of Zoology, Raniganj Girls College, Bardhaman, West Bengal, India.
  • Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Bioengineering, College of Engineering, Texas Tech University, Lubbock, TX, USA.

ORCID-Profile: Akhilesh Kumar Shakya

Zitieren

APA

Firdaus, N. H. W., Mallick, B., Nandakumar, K. S., & Shakya, A. K. (2025). Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases. Journal of The Royal Society Interface, 22(228). https://doi.org/10.1098/rsif.2025.0138

Vancouver

Firdaus NHW, Mallick B, Nandakumar KS, Shakya AK. Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases. Journal of The Royal Society Interface. 2025;22(228). doi:10.1098/rsif.2025.0138

BibTeX
@article{Firdaus2025,
  author = {Firdaus, Nur Hendri Wahyu and Mallick, Buddhadev and Nandakumar, Kutty Selva and Shakya, Akhilesh Kumar},
  title = {Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases},
  journal = {Journal of The Royal Society Interface},
  year = {2025},
  volume = {22},
  number = {228},
  doi = {10.1098/rsif.2025.0138}
}
Kostenlos starten →